RxDoctor Payments Data

Vikramjeet Saini, MD

Interventional Pain Medicine · Glendale, AZNPI 1346569704

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $13,532 of the $20,877 with a category attached, or 64.8%. 24 manufacturers reported payments, led by Abbott at 57.1% of the total. Reporting peaked in 2023 at $6,750 and has fallen 61.5% since, to $2,601 in 2025.

$20,877in general payments, 2019–2025

Across 478 payments — averaging $43.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$12K
  • Spinal Simplicity, LLC$6K
  • Boston Scientific$589
  • Nalu Medical, Inc.$579
  • Saluda Medical Americas, Inc.$474
  • Vertos Medical, Inc.$398
  • plus $1K from 18 others

What the payments were for

  • Consulting fees$3,74318%
  • Travel & lodging$3,60317%
  • Food & beverage$13,53265%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,877 in reported general payments places this provider in the 75th percentile of 64 interventional pain medicine providers in Arizona.

See all interventional pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$276,432
Medicare patients
564
Services billed
7,957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$501
Cephalexin60$328
Oxycodone Hcl49$314
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$187

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →